Page last updated: 2024-09-22

nsc-145,668

Cross-References

ID SourceID
PubMed CID25050
CHEMBL ID1255937
CHEBI ID74843
SCHEMBL ID98180
MeSH IDM0376273

Synonyms (68)

Synonym
nsc-145668
2,2'-o-cyclocytidine hydrochloride
2,2'-anhydroaracytidine hydrochloride
2,2'-anhydrocytarabine hydrochloride
octd hydrochloride
cyclocytidine hydrochloride
2,2'-anhydroarabinosylcytosine hydrochloride
cyclo-c
TL8000113 ,
einecs 233-515-6
1beta-d-arabinofuranosylcytosine, 2,2'-anhydro-, hydrochloride
1-beta-d-arabinofuranosylcytosine, 2,2'-anhydro-, hydrochloride
6h-furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, (2r-(2alpha,3beta,3abeta,9abeta))-
o-2,2'-cyclocytidine monohydrochloride
6h-furo(2',3':4,5)oxazolo(3,2-a)-pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, stereoisomer
ancitabin hydrochlorid
cyclo-cmp hydrochloride
2,2'-anhydro-1beta-d-arabinofuranosylcytosine hydrochloride
cytosine, 1-beta-d-arabinofuranosyl-2,2'-anhydro-, hydrochloride
cytosine, 1beta-d-arabinofuranosyl-2,2'-anhydro-, hydrochloride
2,2'-cyclocytidine, monohydrochloride
2,2'-anhydro-1-beta-d-arabinofuranosylcytosine hydrochloride
nsc 145668
10212-25-6
cyclocytidine
ancitabin hydrochloride
D01651
ancitabine hydrochloride (jan)
MLS001032024
MLS001173324 ,
smr000538927
MLS000766878
3t6920m469 ,
ancitabin hcl
ancitabine hydrochloride [jan]
unii-3t6920m469
ancitabine hcl
CHEMBL1255937
chebi:74843 ,
2,2'-anhydro-1-(beta-d-arabinofuranosyl)cytosine hydrochloride
2,2'-anhydro-(1-beta-d-arabinofuranosylcytosine) hydrochloride
(2r,3r,3as,9ar)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6h-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol hydrochloride
2,2'-cyclocytidine monohydrochloride
S1973
AKOS015896930
ancitabine hydrochloride [mart.]
ancitabine hydrochloride [who-dd]
cyclocytidine hcl
ancitabine hydrochloride [mi]
(2r,3r,3as,9ar)-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-6h-furo(2',3';4,5)oxazolo(3,2-a)pyrimidine-2-methanol, hydrochloride
SCHEMBL98180
MLS006011603
HY-N0093
J-700010
CS-5313
ancitabine (hydrochloride)
(2r,3r,3as,9ar)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydrofuro[1,2]oxazolo[3,4-a]pyrimidin-3-ol
nsc 145668 hcl
AC-8697
KZOWNALBTMILAP-JBMRGDGGSA-N
(2r,3r,3as,9ar)-2-(hydroxymethyl)-6-imino-3,3a,6,9a-tetrahydro-2h-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3-ol hydrochloride
Q27144957
AS-12870
(2r,3r,3as,9ar)-2-(hydroxymethyl)-6-imino-3,3a,6,9a-tetrahydro-2h-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3-olhydrochloride
CCG-267066
EN300-7400814
(2r,4r,5r,6s)-4-(hydroxymethyl)-10-imino-3,7-dioxa-1,9-diazatricyclo[6.4.0.0,2,6]dodeca-8,11-dien-5-ol hydrochloride
Z2044737748

Roles (2)

RoleDescription
antimetaboliteA substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydrochlorideA salt formally resulting from the reaction of hydrochloric acid with an organic base.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glp-1 receptor, partialHomo sapiens (human)Potency1.25890.01846.806014.1254AID624417
TDP1 proteinHomo sapiens (human)Potency0.06910.000811.382244.6684AID686978; AID686979
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency0.13780.00419.984825.9290AID504444; AID720524
eyes absent homolog 2 isoform aHomo sapiens (human)Potency100.00001.199814.641950.1187AID488837
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency14.12540.010323.856763.0957AID2662
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency0.39810.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency0.39810.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency0.39810.15855.287912.5893AID540303
gemininHomo sapiens (human)Potency0.04610.004611.374133.4983AID624297
Guanine nucleotide-binding protein GHomo sapiens (human)Potency10.00001.995325.532750.1187AID624287
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
streptokinase A precursorStreptococcus pyogenes M1 GASEC50 (µMol)77.44400.06008.9128130.5170AID1902; AID1914
Estrogen receptorRattus norvegicus (Norway rat)EC50 (µMol)150.00000.006022.3670130.5170AID1914
Estrogen receptor betaRattus norvegicus (Norway rat)EC50 (µMol)150.00000.006022.3670130.5170AID1914
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (44)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1145783Antiviral activity against Herpes simplex virus HF infected in African green monkey BGM cells after 6 days by plaque reduction assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145781Cytotoxicity against human HeLa cells after 48 hrs by Coulter counting analysis1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145803Antiviral activity against Vaccinia virus IHD infected in African green monkey BGM cells after 6 days by plaque reduction assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145802Cytotoxicity against human HeLa cells after 48 hrs by Coulter counting analysis1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145816Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 200 mg/kg, ip administered 24 hrs post-implantation after 30 days1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145789Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 1000 mg/kg, ip administered as single dose 24 hrs post-implantation measured up to 30 days relative to control1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145811Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 1000 mg/kg, ip administered 24 hrs post-implantation measured up to 30 days relative to control1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145809Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 200 mg/kg, ip administered 24 hrs post-implantation measured up to 30 days relative to control1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145794Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 1000 mg/kg, ip administered as single dose 24 hrs post-implantation after 30 days1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145807Antiviral activity against Influenza virus Ao/WNS infected in monkey LLC-MK2 cells after 5 days by pulp disk diffusion assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145793Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 500 mg/kg, ip administered as single dose 24 hrs post-implantation after 30 days1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145806Antiviral activity against Measles virus infected in African green monkey BGM cells after 5 days by pulp disk diffusion assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145817Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 500 mg/kg, ip administered 24 hrs post-implantation after 30 days1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145805Antiviral activity against Poliovirus type 1 Mahoney infected in African green monkey BGM cells after 5 days by pulp disk diffusion assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID1145797Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 2000 mg/kg, ip administered as single dose 24 hrs post-implantation measured up to 30 days relative to control1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1145804Antiviral activity against Herpes simplex virus HF infected in African green monkey BGM cells after 6 days by plaque reduction assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145818Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 1000 mg/kg, ip administered 24 hrs post-implantation after 30 days1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145824Antitumor activity against mouse L1210 cells allografted in po dosed BDF1 mouse administered 24 hrs post-implantation1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID1145798Toxicity in BDF1 mouse allografted with mouse L1210 cells at 3000 mg/kg, ip1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145784Antiviral activity against Poliovirus type 1 Mahoney infected in African green monkey BGM cells after 5 days by pulp disk diffusion assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145785Antiviral activity against Measles virus infected in African green monkey BGM cells after 5 days by pulp disk diffusion assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145788Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 2500 mg/kg, ip administered as single dose 24 hrs post-implantation measured up to 30 days relative to control1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145810Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 500 mg/kg, ip administered 24 hrs post-implantation measured up to 30 days relative to control1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1145786Antiviral activity against Influenza virus Ao/WNS infected in monkey LLC-MK2 cells after 5 days by pulp disk diffusion assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145787Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 200 mg/kg, ip administered as single dose 24 hrs post-implantation measured up to 30 days relative to control1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145792Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 200 mg/kg, ip administered as single dose 24 hrs post-implantation after 30 days1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1145782Antiviral activity against Vaccinia virus IHD infected in African green monkey BGM cells after 6 days by plaque reduction assay1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's5 (50.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]